THERAVET S.A.
Share · BE0974387194 · A3CSTJ (XFRA)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of THERAVET S.A.
No Price
Company Profile for THERAVET S.A. Share
TheraVet SA, a veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States. The company primarily provides products for osteoarthritis, ligament and tendon injuries, and bone surgery in cats, dogs, and horses. It offers BIOCERA-VET for osseointegration and bone remodelling; and VISCO-VET, an injectable visco-regenerative gel based on hyaluronic acid with anti-inflammatory properties that promotes the effect of active components, as well as acts as a cell colonization supporting tissue regeneration. The company was incorporated in 2017 and is headquartered in Jumet, Belgium.
Company Data
Name THERAVET S.A.
Company TheraVet S.A.
Website
https://www.thera.vet/en
Primary Exchange 
Frankfurt
Frankfurt
WKN A3CSTJ
ISIN BE0974387194
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Gaetan Terrasse
Market Capitalization 10 Mio
Country Belgium
Currency EUR
Employees 0,0 T
Address Rue d'Edimbourg 11b, 6040 Charleroi
IPO Date 2021-06-17
Ticker Symbols
| Name | Symbol |
|---|---|
| Frankfurt | 31A.F |
| Paris | ALVET.PA |
More Shares
Investors who hold THERAVET S.A. also have the following shares in their portfolio:
